Evidence map›Paper›PMID 41091257›Full record

ArticleJournal of robotic surgery2025

Transition to robotic surgery in urologic oncology: a comparative analysis between pre-robotic and robotic eras in a high-volume tertiary center.

Angelo Porreca, Luca Di Gianfrancesco, Davide De Marchi, Francesca Simonetti, Marina Coppola, Antonella Stefano, Pietro Gallina, Antonio Amodeo, Gianpaolo Franzoso, Alessandro Giuriola and 2 more

Abstract readComparative Study
In one paragraph

Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Angelo PorrecaDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.
Luca Di GianfrancescoDepartment of Urology, Humanitas Gavazzeni, Bergamo, Italy. luca.digianfrancesco@gavazzeni.it.
Davide De MarchiDepartment of Urology, Humanitas Gavazzeni, Bergamo, Italy.
Francesca SimonettiDepartment of Urology, Humanitas Gavazzeni, Bergamo, Italy.
Marina CoppolaPharmacy Unit, Veneto Institute of Oncology IOV-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy.
Antonella StefanoVeneto Institute of Oncology (IOV)-IRCCS, Padua, Italy.
Pietro GallinaVeneto Institute of Oncology (IOV)-IRCCS, Padua, Italy.
Antonio AmodeoDepartment of Urology, Veneto Institute of Oncology (IOV)-IRCCS, Headquarter of Castelfranco Veneto, Padua, Italy.
Gianpaolo FranzosoPharmacy Unit, Veneto Institute of Oncology IOV-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy.
Alessandro GiuriolaDepartment of Administration and Management Control Unit, Veneto Institute of Oncology (IOV)-IRCCS, Padua, Italy.
Susy Dal BelloVeneto Institute of Oncology (IOV)-IRCCS, Padua, Italy. susy.dalbello@iov.veneto.it.
Filippo MarinoDepartment of Urology, Humanitas Gavazzeni, Bergamo, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transition from open and laparoscopic techniques to robotic-assisted surgery has transformed the landscape of urologic oncology. However, few studies have directly compared institutional outcomes before and after the adoption of robotic platforms. The objective is to evaluate the clinical and organizational impact of implementing robotic surgery by comparing perioperative outcomes and hospital metrics between the pre-robotic era (2019-2020) and the robotic era (2021-2023) in a high-volume tertiary referral center. A retrospective cohort analysis was conducted on patients undergoing radical prostatectomy (RP), partial nephrectomy (PN), or radical cystectomy (RC) between January 2019 and December 2023. Surgical approach was laparoscopic (RP, PN) or open (RC) during 2019-2020, and robotic for all procedures from 2021 onward. Data on operative time, length of stay (LOS), extended hospitalizations (> 15 days), and 30-day readmissions were collected and compared between the two periods. A total of 1179 procedures were performed, with a marked increase in surgical volume after the implementation of robotic platforms (189 procedures in 2019-2020 vs. 990 in 2021-2023). The robotic era was associated with a significant reduction in median LOS across all procedures: RP (7.5-3.0 days), PN (6.5-4.1 days), and RC (15.5-7.3 days). The rate of extended hospitalizations dropped from 20.3 to 2.1% overall. Readmission rates remained stable, except for RC, which maintained a higher rate in both eras. Operative times remained comparable between the two periods. The transition to robotic-assisted surgery was associated with a substantial increase in surgical volume and significant improvements in perioperative outcomes, including shorter hospital stays and fewer prolonged admissions, while maintaining surgical safety. These results underscore that such improvements are primarily linked to the structured implementation of the program under the guidance of experienced robotic surgeons, rather than to the technology itself.

Indexed as

CystectomyProstatectomyRobotic Surgical ProceduresUrologic NeoplasmsAgedFemaleHospitals, High-VolumeHumansLaparoscopyLength of StayMaleMiddle AgedNephrectomyOperative TimePatient ReadmissionRetrospective StudiesCystectomyHospital metricsNephrectomyOncologyProstatectomyRobotic surgerySurgical outcomesUrology

Identifiers

PMID41091257
PMCPMC12528182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.